全球liquid biopsy marketsize is slated to reach USD 3,362.6 million by 2026 at a CAGR of 21.9% according to a news report published by Polaris Market Research. The report液体活检市场份额，大小，趋势和行业分析报告，[通过技术（PCR微阵列，NGS）;通过样品类型（血液，尿液，唾液，其他体液）;通过生物标志物（Exosomes，CTC，CTDNA）;通过申请;按地区]分部预测，2019-2026provides a comprehensive analysis of present market insights and forecasted future trends.
液体活检是用于诊断癌症发作的常规方法。液体活检的替代名称是流体活组织检查或流体相活检。这主要是一种非侵入性方法，用于在一段时间内跟踪肿瘤和突变。在这些观察到肿瘤未来的帮助下，医生被告知了这种疾病。虽然在早期阶段检测癌症的简单又有乐器，但它的用途涉及其采用。液体活组织检查产品市场具有缺点，这是由于组织活检在很大程度上是由于后者的缺点。
Drivers to the market potential are the increasing number of patients being diagnosed with various types of cancer. The free trials accompanying surgery motivates growth. Minimal invasive surgery method unique to liquid biopsy market cap, invokes huge demand impacting market growth over forthcoming years.
A significant driver to growth of liquid biopsy is the reduced number of surgical invasions. This encouraging sign makes it one of the most adopted substitutes for tissue biopsy. An increasing trend followed by key players to shift focus onto research and development activities aiding strategic M&A improves market strength dramatically.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:
//m.ptlymt.com/Industry-analysis in/liquid-biopsy-market.
考虑到技术的基础，单基因分析和多基因平行分析（NGS）主导液检癌症市场规模。ngs表示一个实例的多种疾病的诊断。PCR是一种分析基因突变的方法。
液体活检市场2018年液体活检市场中的另一类区别是基于样品类型。样品在血液，唾液，尿液和其他体液的基础上进行分段。血液样本是仿常规分析的最佳样品类型，因为血液含有无细胞的DNA，循环细胞和外来体，为它们提供易于检测，导致在人体中检测癌细胞。
基于生物标志物类型、全球市场前景to 2026 is segmented into exosomes, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA). CTC biomarkers govern largest market share owing to high awareness levels and accurate tracking results of cancerous cells in the body. CTC marker makes early forays in the initial stages of detection of cancer itself.
North America is holding coveted position as per geography in market cap during forecast period. Increased facilitators for diagnosis of cancer and rising number of patients suffering from cancer are factors promoting growth of market. Asia Pacific is exhibited to grow at a faster rate during forecast period.
The major players operating in market include Roche Diagnostics, Illumina Inc., Myriad Genetics, Inc., RainDance Technologies, Inc. among others.
乐动体育软件最新版POLARIS市场研究在样品类型，应用，生物标志物类型和区域的基础上分段了全球液体活检市场：
Liquid Biopsy Sample Type Outlook (Revenue USD Millions 2015-2026)
- Blood
- 尿
- Saliva
液体活检应用前景（收入USD 2015-2026）
- 分子健康监测
- Therapy Selection For Other Meta cancer
- MBS的治疗选择
液体活检生物标志物类型展望（收入USD 2015-2026）
- Exosomes
- Circulating tumor cells (CTC)
- Circulating tumor DNA (ct DNA)
液体活检区域展望（收入USD百万2015-2026）
- North America
- America
- 加拿大
- 欧洲
- 德国
- UK
- 法国
- 意大利
- Asia Pacific
- 印度
- China
- Japan
- Latin America
- 墨西哥
- 巴西
- Middle East and Africa